Literature DB >> 10371077

Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody.

K Tanaka1, M Tanaka, T Inuzuka, R Nakano, S Tsuji.   

Abstract

Paraneoplastic sensory neuronopathy (PSN) has been shown to harbor characteristic anti-neuronal autoantibody 'anti-Hu' in their sera and cerebrospinal fluid. Creation of animal models exhibiting clinical or pathological features seen in PSN by means of passive transfer of anti-Hu positive IgG has not been achieved. Although, anti-Hu antibody was shown to induce neuronal cell lysis in vitro, this result has not been reproduced so far. Since prominent T cell infiltration are seen in the central nervous system and posterior spinal ganglion of the patients with anti-Hu syndrome, we studied cytotoxic T cell (CTL) activity in peripheral mononuclear cells from a patient with PSN harboring anti-Hu antibody. The activated CD8+ T cells from the patient's venous blood were shown to lyse her own fibroblasts which were incubated with interferon-gamma to induce HLA class I molecules on their surface and the recombinant HuD protein was injected into the cells by microinjector. This is the first report showing the existence of CTL in a patient with PSN.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371077     DOI: 10.1016/s0022-510x(99)00029-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Paraneoplastic neurologic syndromes.

Authors:  Steven Vernino
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

2.  T cell response to Hu-D peptides in patients with anti-Hu syndrome.

Authors:  A Rousseau; B Benyahia; J Dalmau; F Connan; J-G Guillet; J-Y Delattre; J Choppin
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 3.  Autoimmune epilepsies.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 4.  Diagnosis and management of paraneoplastic neurologic disorders.

Authors:  Myrna R Rosenfeld; Josep Dalmau
Journal:  Curr Treat Options Oncol       Date:  2013-12

Review 5.  Immunity and Inflammation in Epilepsy.

Authors:  Annamaria Vezzani; Bethan Lang; Eleonora Aronica
Journal:  Cold Spring Harb Perspect Med       Date:  2015-12-18       Impact factor: 6.915

Review 6.  Encephalitis and epilepsy.

Authors:  Jan Bauer; Christian G Bien
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

7.  Isolated adrenocorticotropic hormone deficiency as a form of paraneoplastic syndrome.

Authors:  Hironori Bando; Genzo Iguchi; Keitaro Kanie; Hitoshi Nishizawa; Ryusaku Matsumoto; Yasunori Fujita; Yukiko Odake; Kenichi Yoshida; Kentaro Suda; Hidenori Fukuoka; Keiko Tanaka; Wataru Ogawa; Yutaka Takahashi
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 8.  T-cells in human encephalitis.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 9.  Cell-mediated immune responses in paraneoplastic neurological syndromes.

Authors:  Mikolaj Piotr Zaborowski; Slawomir Michalak
Journal:  Clin Dev Immunol       Date:  2013-12-30

10.  The associations between serum vascular endothelial growth factor, tumor necrosis factor and interleukin 4 with the markers of blood-brain barrier breakdown in patients with paraneoplastic neurological syndromes.

Authors:  Slawomir Michalak; Alicja Kalinowska-Lyszczarz; Joanna Rybacka-Mossakowska; Mikolaj Zaborowski; Wojciech Kozubski
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.